- Policy Interpretation of the Implementation Opinions of the ...
05/14 - Implementation Opinions of NMPA on “Artificial Intelligence ...05/12
- NMPA holds special training program on quality improvement o...04/21
- Implementation Opinions on “Artificial Intelligence + Drug R...04/17
- Meeting on Rare Disease Drug Development Held03/06
- China revises drug administration regulations to spur innova...02/05
International Cooperation- Yang Sheng meets with associate commissioner for global poli...02/11
- Yang Sheng meets with WHO officials11/13
- Li Li meets with CEO of HSA of Singapore09/18
- Li Li meets with secretary for health of HKSAR 09/15
- NMPA Elected as a Member of the ICH Management Committee10/29
- NMPA Issued Announcement on Releasing M4: Common Technical D...10/29
- Implementation Opinions of NMPA on “Artificial Intelligence ...05/14
- Policy Interpretation of the Implementation Opinions of the ...05/14
- Implementation Opinions on “Artificial Intelligence + Drug R...04/17
- China revises drug administration regulations to spur innova...02/05
- Technical Requirements for Registration Application at Pilot...12/20
- Common problems and technical requirements of replication ...12/20
